Neuromobility

AdapGAIT - Study on Preliminary Safety and Efficacy of Adaptive DBS Aligned to Locomotor States to Improve Locomotor Functions in Parkinson's Patients

This study explores whether adaptive deep brain stimulation (aDBS) can safely and effectively improve walking and balance problems in people with Parkinson’s disease.

AdapGAIT – Studie om preliminär säkerhet och effekt av adaptiv DBS anpassad till lokomotoriska tillstånd för att förbättra lokomotoriska funktioner hos patienter med Parkinson

Overview

This study explores whether adaptive deep brain stimulation (aDBS) can safely and effectively improve walking and balance problems in people with Parkinson’s disease. Unlike standard DBS, which delivers constant stimulation, aDBS adjusts therapy in real time based on recorded brain activity. The goal is to address gait and mobility issues that current treatments cannot adequately improve.

Eligibility Criteria

Inclusion Criteria:

• Diagnosed with typical or atypical forms of Parkinson's disease; Suffering from gait or balance disorders;

• Implanted with a full Medtronic Percept PC suite (neurostimulator Percept PC B35200; with bilateral leads (Medtronic Legacy leads (Models 3387 and 3389) or Medtronic SenSightTM Directional Lead (models B33015 and B33005)) and lead extensions (Medtronic extensions (Model 37085 and 37086) or SenSightTM extension (model B34000)), or Medtronic SenSightTM Connector Plug (Model B31061));

• Exhibit modulations in at least one frequency band of the LFP that are related to locomotor states or gait deficits.

• Aged 18 years-old or more;

• Must provide and sign the study's Informed Consent prior to any study-related procedures;

• Able to understand and interact with the study team in French;

• Agree to comply in good faith with all conditions of the recordings, and to attend all required study procedures

Exclusion Criteria:

• DBS (hardware or programs) incompatible with BrainSense recordings, such as use of interleaved DBS programs or pocket adaptors;

• High impedances or artefacts in neural signals that obstruct the detection of motor-related biomarkers for adaptive DBS;

• Changes in DBS amplitudes (increase / decrease) not well tolerated;

• Secondary causes of gait problems independent of PD;

• Inability to follow the procedures of the study independently;

• History of major psychiatric disorders or major neurocognitive disorders, as considered by the investigators in according with treating physicians;

• Major changes in PD treatments planned within the course of the study;

• History of drug or alcohol abuse in the past 5 years;

• Pregnancy;

• Participation in another investigational study in the preceding 30 days or during the study

Study timeline

01/25 Study Start

01/27 Study conclusion

10 Participants

Project Partners

CHUV

CHUV

Prof. Eduardo Martin Moraud.

Phone Number: +41213142455

Email: Eduardo.Martin-Moraud@chuv.ch

Your privacy choices

Essential storage remembers your preferences. Optional Google Analytics helps us understand how the website is used. It stays off unless you allow it.

HubSpot forms connect only when you choose to load a form. Form submission and subscription choices are made inside the form.

Read our privacy notice